
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Radiation‐Induced Immunogenic Cell Death for Cancer Radioimmunotherapy
Teng Liu, Pei Pei, Wenhao Shen, et al.
Small Methods (2023) Vol. 7, Iss. 5
Closed Access | Times Cited: 46
Teng Liu, Pei Pei, Wenhao Shen, et al.
Small Methods (2023) Vol. 7, Iss. 5
Closed Access | Times Cited: 46
Showing 1-25 of 46 citing articles:
Remodeling Tumor Immune Microenvironment by Using Polymer-Lipid-Manganese Dioxide Nanoparticles with Radiation Therapy to Boost Immune Response of Castration-Resistant Prostate Cancer
Abdulmottaleb E. Zetrini, HoYin Lip, Azhar Z. Abbasi, et al.
Research (2023) Vol. 6
Open Access | Times Cited: 35
Abdulmottaleb E. Zetrini, HoYin Lip, Azhar Z. Abbasi, et al.
Research (2023) Vol. 6
Open Access | Times Cited: 35
Mechanisms of Action in FLASH Radiotherapy: A Comprehensive Review of Physicochemical and Biological Processes on Cancerous and Normal Cells
James C. L. Chow, Harry E. Ruda
Cells (2024) Vol. 13, Iss. 10, pp. 835-835
Open Access | Times Cited: 13
James C. L. Chow, Harry E. Ruda
Cells (2024) Vol. 13, Iss. 10, pp. 835-835
Open Access | Times Cited: 13
Engineered bacteria in tumor immunotherapy
Hua Chen, Yinrui Zhu, Chonghai Zhang, et al.
Cancer Letters (2024) Vol. 589, pp. 216817-216817
Closed Access | Times Cited: 11
Hua Chen, Yinrui Zhu, Chonghai Zhang, et al.
Cancer Letters (2024) Vol. 589, pp. 216817-216817
Closed Access | Times Cited: 11
Emerging role of immunogenic cell death in cancer immunotherapy: Advancing next-generation CAR-T cell immunotherapy by combination
Zhaokai Zhou, Yumiao Mai, Ge Zhang, et al.
Cancer Letters (2024) Vol. 598, pp. 217079-217079
Closed Access | Times Cited: 11
Zhaokai Zhou, Yumiao Mai, Ge Zhang, et al.
Cancer Letters (2024) Vol. 598, pp. 217079-217079
Closed Access | Times Cited: 11
Biomaterials to regulate tumor extracellular matrix in immunotherapy
Yujie Zhang, Xuexue Dong, Yanxiang Zhang, et al.
Journal of Controlled Release (2024) Vol. 376, pp. 149-166
Closed Access | Times Cited: 9
Yujie Zhang, Xuexue Dong, Yanxiang Zhang, et al.
Journal of Controlled Release (2024) Vol. 376, pp. 149-166
Closed Access | Times Cited: 9
NIR‐II Fluorescent Nanotheranostics with a Switchable Irradiation Mode for Immunogenic Sonodynamic Therapy
Minhui Cui, Dongsheng Tang, Hanchen Zhang, et al.
Advanced Materials (2024)
Closed Access | Times Cited: 8
Minhui Cui, Dongsheng Tang, Hanchen Zhang, et al.
Advanced Materials (2024)
Closed Access | Times Cited: 8
Regulation of Ion Homeostasis for Enhanced Tumor Radio‐Immunotherapy
Rui Qian, Xuan Yi, Teng Liu, et al.
Advanced Science (2023) Vol. 10, Iss. 32
Open Access | Times Cited: 22
Rui Qian, Xuan Yi, Teng Liu, et al.
Advanced Science (2023) Vol. 10, Iss. 32
Open Access | Times Cited: 22
X‐Ray‐Induced Drug Release for Cancer Therapy
Hui Liu, Jun Zhao, Yufei Xue, et al.
Angewandte Chemie International Edition (2023) Vol. 62, Iss. 39
Open Access | Times Cited: 20
Hui Liu, Jun Zhao, Yufei Xue, et al.
Angewandte Chemie International Edition (2023) Vol. 62, Iss. 39
Open Access | Times Cited: 20
Recent preclinical and clinical advances in radioimmunotherapy for non-Hodgkin’s lymphoma
Hiroki Goto, Yoshioki Shiraishi, Seiji Okada
Exploration of Targeted Anti-tumor Therapy (2024) Vol. 5, Iss. 1, pp. 208-224
Open Access | Times Cited: 7
Hiroki Goto, Yoshioki Shiraishi, Seiji Okada
Exploration of Targeted Anti-tumor Therapy (2024) Vol. 5, Iss. 1, pp. 208-224
Open Access | Times Cited: 7
Nanoparticle-mediated immunogenic cell death for cancer immunotherapy
Haolong Qi, Yuan Li, Yingjie Geng, et al.
International Journal of Pharmaceutics (2024) Vol. 656, pp. 124045-124045
Closed Access | Times Cited: 7
Haolong Qi, Yuan Li, Yingjie Geng, et al.
International Journal of Pharmaceutics (2024) Vol. 656, pp. 124045-124045
Closed Access | Times Cited: 7
Biomaterials-mediated radiation-induced diseases treatment and radiation protection
Jianping Man, Yanhua Shen, Yujie Song, et al.
Journal of Controlled Release (2024) Vol. 370, pp. 318-338
Closed Access | Times Cited: 7
Jianping Man, Yanhua Shen, Yujie Song, et al.
Journal of Controlled Release (2024) Vol. 370, pp. 318-338
Closed Access | Times Cited: 7
Engineered bacteria breach tumor physical barriers to enhance radio-immunotherapy
Yanxiang Zhang, Yue Liu, Tingting Li, et al.
Journal of Controlled Release (2024) Vol. 373, pp. 867-878
Closed Access | Times Cited: 7
Yanxiang Zhang, Yue Liu, Tingting Li, et al.
Journal of Controlled Release (2024) Vol. 373, pp. 867-878
Closed Access | Times Cited: 7
A pH-Sensitive Nanoparticle as Reactive Oxygen Species Amplifier to Regulate Tumor Microenvironment and Potentiate Tumor Radiotherapy
Xiaomei Jiang, Xiaohong Jiang, Dongjie Wu, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 709-725
Open Access | Times Cited: 6
Xiaomei Jiang, Xiaohong Jiang, Dongjie Wu, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 709-725
Open Access | Times Cited: 6
Potent Amphiphilic Poly(Amino Acid) Nanoadjuvant Delivers Biomineralized Ovalbumin for Photothermal-Augmented Immunotherapy
Xiaoyi Zhao, Yixin Zheng, Yian Liu, et al.
ACS Nano (2024) Vol. 18, Iss. 46, pp. 32088-32102
Closed Access | Times Cited: 5
Xiaoyi Zhao, Yixin Zheng, Yian Liu, et al.
ACS Nano (2024) Vol. 18, Iss. 46, pp. 32088-32102
Closed Access | Times Cited: 5
A radiobiological perspective on radioresistance or/and radiosensitivity of head and neck squamous cell carcinoma
Chenxi Li, Xiaorong Tan, Wei Wei, et al.
Reports of Practical Oncology & Radiotherapy (2024) Vol. 28, Iss. 6, pp. 809-822
Open Access | Times Cited: 4
Chenxi Li, Xiaorong Tan, Wei Wei, et al.
Reports of Practical Oncology & Radiotherapy (2024) Vol. 28, Iss. 6, pp. 809-822
Open Access | Times Cited: 4
Tumor Microenvironment Reprogrammed Bimetallic Hybrid Nanostimulator for Triggering Radio‐Cuproptosis‐Immunotherapy
Xiaohong Jiang, Jin Wang, Weijie Huang, et al.
Advanced Healthcare Materials (2024) Vol. 13, Iss. 30
Open Access | Times Cited: 4
Xiaohong Jiang, Jin Wang, Weijie Huang, et al.
Advanced Healthcare Materials (2024) Vol. 13, Iss. 30
Open Access | Times Cited: 4
DNA Nanostructures‐Based In Situ Cancer Vaccines: Mechanisms and Applications
Bingyu Lin, Yanfei Liu, Qi‐Wen Chen, et al.
Small Methods (2025)
Open Access
Bingyu Lin, Yanfei Liu, Qi‐Wen Chen, et al.
Small Methods (2025)
Open Access
Comparison of radiobiological effects induced by radiolabeled antibodies in human cancer cells and fungal cells
Jonathan Bonet Ramírez, Kevin J. H. Allen, Mackenzie E. Malo, et al.
International Journal of Radiation Biology (2025), pp. 1-10
Closed Access
Jonathan Bonet Ramírez, Kevin J. H. Allen, Mackenzie E. Malo, et al.
International Journal of Radiation Biology (2025), pp. 1-10
Closed Access
Novel bio-carriers for radionuclide delivery in cancer radiotherapy
Lishan Wang, Qing‐Yu He, Jianping Man, et al.
Coordination Chemistry Reviews (2025) Vol. 533, pp. 216557-216557
Closed Access
Lishan Wang, Qing‐Yu He, Jianping Man, et al.
Coordination Chemistry Reviews (2025) Vol. 533, pp. 216557-216557
Closed Access
Harnessing the power of traceable system C-GAP: homologous-targeting to fire up T-cell immune responses with low-dose irradiation
Weijie Zhuang, Kuangwu Pan, Jie Wu, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access
Weijie Zhuang, Kuangwu Pan, Jie Wu, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access
TREM2 scFv‐Engineering Escherichia coli Displaying Modulation of Macrophages to Boost Cancer Radio‐Immunotherapy
Yifan Wang, Anqi Dong, Jianping Man, et al.
Advanced Materials (2025)
Closed Access
Yifan Wang, Anqi Dong, Jianping Man, et al.
Advanced Materials (2025)
Closed Access
Ultrasmall Bi@Au Schottky Heterojunction with a High Potential Barrier for Amplifying Radioimmunotherapy
Chuang Shen, Xianghong Niu, Jiaxu Zhang, et al.
ACS Nano (2025)
Closed Access
Chuang Shen, Xianghong Niu, Jiaxu Zhang, et al.
ACS Nano (2025)
Closed Access
Reengineering the Tumor Oxygen Microenvironment in Radiotherapy to Enhance T‐Cell Function for Radio‐Immunotherapy
Zetong Chen, Qing‐Yu He, Rui Qian, et al.
Advanced Functional Materials (2025)
Closed Access
Zetong Chen, Qing‐Yu He, Rui Qian, et al.
Advanced Functional Materials (2025)
Closed Access
In vitro and in vivo study on the treatment of non-small cell lung cancer with radionuclide labeled PD-L1 nanobody
Mengqin Zhu, Jiajia Zhang, Mengdie Yang, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 11, pp. 8429-8442
Closed Access | Times Cited: 9
Mengqin Zhu, Jiajia Zhang, Mengdie Yang, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 11, pp. 8429-8442
Closed Access | Times Cited: 9
Leveraging Radiation‐triggered Metal Prodrug Activation Through Nanosurface Energy Transfer for Directed Radio‐chemo‐immunotherapy
Feixia Ruan, Hui Fang, Fangman Chen, et al.
Angewandte Chemie International Edition (2023) Vol. 63, Iss. 10
Closed Access | Times Cited: 9
Feixia Ruan, Hui Fang, Fangman Chen, et al.
Angewandte Chemie International Edition (2023) Vol. 63, Iss. 10
Closed Access | Times Cited: 9